Opioid Addiction and Substance Use Treatments

September 11, 2024

What You Need to Know About Opioid Addiction

Addiction is a complex, chronic disease that impacts many throughout the world, and can be challenging to overcome. Addiction can also be diagnosed as Substance Use Disorder (SUD) and range from mild to severe levels of addiction, involving overwhelming desire for the substance, increased dependence on the substance, and withdrawal symptoms if the substance is unobtainable. In the United States, over 20 million people have SUD, including alcohol and drug use disorders. Addiction and SUD is treatable, through substance use treatment, misuse management, and a healthy support system.


Opioids, also referred to as narcotics, are a common substance that have high addiction potential. Opioids are commonly prescribed by doctors to help manage moderate to severe pain, typically post surgical operations. However, the combination of pain reduction and the sense of euphoria many experience while taking opioids can lead to Opioid Use Disorder, or an opioid addiction. Medical professionals help to reduce this likelihood is by prescribing milder doses for a shorter period of time, and addiction is less likely to occur as long as the prescription instructions are followed accordingly.


Many factors play a role in addiction and OUD, including:

  • How the substance is administered (injected, taken orally, etc.)
  • The rate at which the substance triggers the 'reward pathway' in the brain
  • How long is takes to feel the substance's effects
  • Level of tolerance
  • Severity of withdrawal symptoms
  • Environmental and biological components


Due to the complexity of SUD and opioid addiction, and the multiple factors that impact each person differently, it is essential to seek help from medical professionals, such as doctors and psychiatrists, who can provide the necessary support you or a loved one needs to manage the condition. Opioid addiction specifically affects approximately three million people in the United States, and be managed through a personalized treatment plan that may include outpatient counseling, in-patient care and counseling, medication-assisted treatment, and methods of psychotherapy. 

Contact Our Primary Care Providers to Learn More

Park Avenue Medical has been serving Meriden, Cheshire, Middletown, North Haven, and Wallingford, CT since 2012, providing empathetic and high-quality substance use treatments, substance misuse management, and treatment options for opioid addiction. Help is available, and if you or a loved one are struggling with a Substance Use Disorder, please contact our primary care providers today to learn more about the signs of addiction and how we can help.

May 24, 2024
Discover FDA-approved weight loss injections like Ozempic and Wegovy, designed to manage obesity and improve health. Find your path to better wellness today.
Tackling Treatment-Resistant Depression
June 28, 2020
Discover innovative options like Spravato® nasal spray for managing treatment-resistant depression. Find relief with expert care from Park Avenue Medical.
The Nitty Gritty Of Trigger Point Injections
June 28, 2020
Learn how trigger point injections help relieve chronic pain. Explore the process, benefits, and how we tailor treatments to your needs at Park Avenue Medical.
New Study on Bionic Pancreases
June 21, 2020
A new study in the New England Journal of Medicine finds that a bionic pancreas was more effective in controlling hemoglobin A1C levels compared to standard care.
Welcome to Our Website
June 21, 2020
Explore Park Avenue Medical’s services, patient resources, and updates. Learn about substance misuse treatment, chronic pain relief, and more on our website.
When You Unlock Your Potential
June 21, 2020
Read how ADHD treatment transformed a student’s life, improving focus and academic performance. Discover personalized care at Park Avenue Medical.
New Medication Tirzepatide for Weight Loss
June 21, 2020
Learn about Tirzepatide, a groundbreaking medication in clinical trials showing significant weight loss potential. Explore its promising results today.
New Medicatoin Retatrutide for Weight Loss in Phase 2 Trials
June 21, 2020
Explore Retatrutide, a promising new weight loss medication showing remarkable outcomes in phase 2 trials. Stay informed about revolutionary treatments.